NCT05775874 2023-03-20
A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC
Abbisko Therapeutics Co, Ltd
Phase 2 Unknown
Clinical Trials
7 trialsNCT05445648 2022-12-28
CBPTMI
First Affiliated Hospital Xi'an Jiaotong University
Phase 2 Unknown
NCT04730219 2022-11-30
Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma
Tianjin Medical University Second Hospital
Phase 2 Unknown
NCT05580354 2022-10-14
Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer
Ruijin Hospital
Phase 4 Unknown
NCT05401279 2022-08-18
Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer
RenJi Hospital
Phase 2 Unknown
NCT04813107 2022-02-22
ANTICIPATE
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Phase 1/2 Unknown
NCT04922047 2021-06-11
TACBIN-01
RenJi Hospital
Phase 1/2 Unknown